Strategies for controlled delivery of growth factors and cells for bone regeneration

Advanced Drug Delivery Reviews

Volumn 64, Issue 12, 2012, Pages 1292-1309

  Vo, Tiffany N ^a   Kasper, F Kurtis ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

Bone tissue engineering; Cells; Controlled delivery; Growth factors; Scaffolds

Indexed keywords

BIOACTIVE MOLECULES; BONE FORMATION; BONE HEALING; BONE REGENERATION; BONE TISSUE ENGINEERING; CARRIER SYSTEMS; CELL DELIVERY; CELLULAR INFILTRATION; CONTROLLED DELIVERY; DELIVERY SYSTEMS; EXTRACELLULAR; GROWTH FACTOR; IN-VITRO; RELEASE KINETICS; TISSUE REPAIR; WOUND HEALING PROCESS;

BIOACTIVITY; BONE; CELLS; CYTOLOGY; ENZYME INHIBITION; SCAFFOLDS; TISSUE;

SCAFFOLDS (BIOLOGY);

ADENOVIRUS VECTOR; APATITE; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 9; CALCIUM PHOSPHATE; COLLAGEN; CYCLOOXYGENASE 2; FIBRIN; FIBROBLAST GROWTH FACTOR 2; GELATIN; GROWTH FACTOR; HEPARIN; HYDROXYAPATITE; LIM PROTEIN; NAKED DNA; OSTEOGENIC PROTEIN 1; PARVOVIRUS VECTOR; PLASMID VECTOR; POLYGLACTIN; POLYLACTIC ACID; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RETROVIRUS VECTOR; SILK FIBROIN; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; CELL INFILTRATION; CELL PROLIFERATION; CELL THERAPY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ELECTROPORATION; FRACTURE HEALING; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; ORTHOPEDIC SURGERY; OSSIFICATION; OSTEOCYTE; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; TISSUE REPAIR; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXTRACELLULAR MATRIX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84865041045     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.01.016     Document Type: Review

References (290)

1. Greenwald A.S., Oxon D.P., Boden S.D., Goldberg V.M., Khan Y. Bone graft substitutes: facts, fictions & applications. American Academy of Orthopaedic Surgeons 2001.
2. Laurencin C., Khan Y., El-Amin S.F. Bone graft substitutes. Exp. Rev. Med. Dev. 2006, 3:49-57.
3. Belthur M.V., Conway J.D., Jindal G., Ranade A., Herzenberg J.E. Bone graft harvest using a new intramedullary system. Clin. Orthop. 2008, 466:2973-2980.
4. Conway J.D. Autograft and nonunions: morbidity with intramedullary bone graft versus iliac crest bone graft. Orthop. Clin. North Am. 2010, 41:75-84.
5. Kim D.H., Rhim R., Li L., Martha J., Swaim B.H., Banco R.J., Jenis L.G., Tromanhauser S.G. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J. 2009, 9:886-892.
6. Schwartz C.E., Martha J.F., Kowalski P., Wang D.A., Bode R., Li L., Kim D.H. Prospective evaluation of chronic pain associated with posterior autologous iliac crest bone graft harvest and its effect on postoperative outcome. Health Qual. Life Outcomes 2009, 7:49.
7. Sen M.K., Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?. Injury 2007, 38(Suppl 1):S75-S80.
8. J.R. Lieberman, A. Daluiski, T.A. Einhorn, The role of growth factors in the repair of bone. Biology and clinical applications., J. Bone Joint Surg., 84-A (2002) 1032-1044.
9. Nauth A., Ristevski B., Li R., Schemitsch E.H. Growth factors and bone regeneration: how much bone can we expect?. Injury 2011, 42:574-579.
10. Seeherman H., Wozney J.M. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytok. Growth Fact. Rev. 2005, 16:329-345.
11. Jäger M., Hernigou P., Zilkens C., Herten M., Li X., Fischer J., Krauspe R. Cell therapy in bone healing disorders. Orthop. Rev. 2010, 2:79-87.
12. Kim S.-J., Shin Y.-W., Yang K.-H., Kim S.-B., Yoo M.-J., Han S.-K., Im S.-A., Won Y.-D., Sung Y.-B., Jeon T.-S., Chang C.-H., Jang J.-D., Lee S.-B., Kim H.-C., Lee S.-Y. A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast(Ossron) injection to treat fractures. BMC Musculoskel. Dis. 2009, 10:20.
13. Mooney D.J., Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2008, 2:205-213.
14. Malafaya P.B., Silva G.A., Baran E.T., Reis R.L. Drug delivery therapies II. Strategies for delivering bone regenerating factors. Mater. Sci. 2002, 6:297-312.
15. G.L. Barnes, P.J. Kostenuik, L.C. Gerstenfeld, T.A. Einhorn, Growth factor regulation of fracture repair, J. Bone Miner. Res., 14 (1999).
16. Schindeler A., McDonald M.M., Bokko P., Little D.G. Bone remodeling during fracture repair: the cellular picture. Semin. Cell Dev. Biol. 2008, 19:459-466.
17. Laffargue P., Hildebrand H.F., Rtaimate M., Frayssinet P., Amoureux J.P., Marchandise X. Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects. Bone 1999, 25:55S-58S.
18. Lee K., Silva E.A., Mooney D.J. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J. Royal Soc. Interf 2011, 8:153-170.
19. Lee S.-H., Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv. Drug Deliv. Rev 2007, 59:339-359.
20. Ramoshebi L.N., Matsaba T.N., Teare J., Renton L., Patton J., Ripamonti U. Tissue engineering: TGF-beta superfamily members and delivery systems in bone regeneration. Exp. Rev. Mol. Med. 2002, 4:1-11.
21. Celeste A., Iannazzi J., Taylor R., Hewick R., Rosen V., Wang E., Wozney J. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:9843-9847.
22. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
23. Aufdemorte T., Fox W., Holt R., McGuff H., Ammann A., Beck L. An intraosseous device for studies of bone-healing: the effect of transforming growth-factor beta. J. Bone Joint Surg. 1992, 74:1153-1161.
24. Bosch C., Melsen B., Gibbons R., Vargervik K. Human recombinant transforming growth factor-[beta] in healing of calvarial bone defects. J. Craniofac. Surg. 1996, 7:300-310.
25. Heckman J., Ehler W., Brooks B.P., Aufdemorte T.B., Lohmann C.H., Morgan T., Boyan B.D. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. J. Bone Joint Surg. 1999, 81:1717-1729.
26. McKinney L., Hollinger J.O. A bone regeneration study: transforming growth factor-[beta]1 and its delivery. J. Craniofac. Surg. 1996, 7:36-45.
27. Nikolidakis D., Meijer G.J., Oortgiesen D.A., Walboomers X.F., Jansen J.A. The effect of a low dose of transforming growth factor beta1 (TGF-beta1) on the early bone-healing around oral implants inserted in trabecular bone. Biomaterials 2009, 30:94-99.
28. Ueda H., Hong L., Yamamoto M., Shigeno K., Inoue M., Toba T., Yoshitani M., Nakamura T., Tabata Y., Shimizu Y. Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits. Biomaterials 2002, 23:1003-1010.
29. Vehof J.W.M., Fisher J.P., Dean D., van der Waerden J.-P.C.M., Spauwen P.H.M., Mikos A.G., Jansen J.A. Bone formation in transforming growth factor beta-1-coated porous poly (propylene fumarate) scaffolds. J. Biomed. Mater. Res. 2002, 60:241-251.
30. Ripamonti U. Soluble osteogenic molecular signals and the induction of bone formation. Biomaterials 2006, 27:807-822.
31. Fischer J., Kolk A., Wolfart S., Pautke C., Warnke P.H., Plank C., Smeets R. Future of local bone regeneration - protein versus gene therapy. Int. J. Oral Maxillof. Surg. 2011, 39:54-64.
32. Kimelman N., Pelled G., Helm G.A., Huard J., Schwarz E.M., Gazit D. Review: gene- and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng. 2007, 13:1135-1150.
33. Kirker-Head C. Potential applications and delivery strategies for bone morphogenetic proteins. Adv. Drug Deliv. Rev 2000, 43:65-92.
34. Brandi M.L., Collin-Osdoby P. Vascular biology and the skeleton. J. Bone Miner. Res. 2006, 21:183-192.
35. Kanczler J., Oreffo R. Osteogenesis and angiogenesis: the potential for engineering bone. Eur. Cells Mater. 2008, 15:100-114.
36. Gerber H.P., Ferrara N. Angiogenesis and bone growth. Tr. Cardiovasc. Med. 2000, 10:223-228.
37. Geiger F., Bertram H., Berger I., Lorenz H., Wall O., Eckhardt C., Simank H.-G., Richter W. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J. Bone Miner. Res. 2005, 20:2028-2035.
38. Kleinheinz J., Stratmann U., Joos U., Wiesmann H. VEGF-activated angiogenesis during bone regeneration. J. Oral Maxillofac. Surg. 2005, 63:1310-1316.
39. Kaigler D., Wang Z., Horger K., Mooney D.J., Krebsbach P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J. Bone Miner. Res. 2006, 21:735-744.
40. Leach J.K., Kaigler D., Wang Z., Krebsbach P.H., Mooney D.J. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 2006, 27:3249-3255.
41. Street J., Bao M., DeGuzman L., Bunting S., Peale F.V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J.L., Daugherty A., van Bruggen N., Redmond H.P., Carano R.A.D., Filvaroff E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9656-9661.
42. Tarkka T., Sipola A., Jamsa T., Soini Y., Yla-Herttuala S., Juha T., Hautala T. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J. Gene Med. 2003, 5:560-566.
43. Huang Y.-C., Kaigler D., Rice K.G., Krebsbach P.H., Mooney D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 2005, 20:848-857.
44. Kempen D.H.R., Lu L., Heijink A., Hefferan T.E., Creemers L.B., Maran A., Yaszemski M.J., Dhert W.J.A. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009, 30:2816-2825.
45. Patel Z.S., Young S., Tabata Y., Jansen J.A., Wong M.E.K., Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43:931-940.
46. Peng H., Usas A., Olshanski A., Ho A.M., Gearhart B., Cooper G.M., Huard J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J. Bone Miner. Res. 2005, 20:2017-2027.
47. Peng H., Wright V., Usas A., Gearhart B., Shen H.-C., Cummins J., Huard J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 2002, 110:751-759.
48. Sheller M.R., Crowther R.S., Kinney J.H., Yang J., Di Jorio S., Breunig T., Carney D.H., Ryaby J.T. Repair of rabbit segmental defects with the thrombin peptide, TP508. J. Orthop. Res. 2004, 22:1094-1099.
49. Wozney J.M., Seeherman H.J. Protein-based tissue engineering in bone and cartilage repair. Curr. Opin. Biotech. 2004, 15:392-398.
50. Mountziaris P.M., Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng. Part B Rev. 2008, 14:179-186.
51. Mountziaris P.M., Spicer P.P., Kasper F.K., Mikos A.G. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng. Part B Rev. 2011, 00:1-10.
52. Carano R.A.D., Filvaroff E.H. Angiogenesis and bone repair. Drug Discov. Today 2003, 8:980-989.
53. Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
54. Kempen D.H.R., Lu L., Hefferan T.E., Creemers L.B., Heijink A., Maran A., Dhert W.J.A., Yaszemski M.J. Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration. Bone 2010, 16:3769-3777.
55. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., Hodsman A.B., Eriksen E.F., Ish-Shalom S., Genant H.K., Wang O., Mitlak B.H. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 2001, 344:1434-1441.
56. Almeida J.D., Arisawa E.A., da Rocha R.F., Carvalho Y.R. Effect of calcitonin on bone regeneration in male rats: a histomorphometric analysis. Int. J. Oral Maxillof. Surg. 2007, 36:435-440.
57. Weiss R.E., Singer F.R., Gorn A.H., Hofer D.P., Nimni M.E. Calcitonin stimulates bone formation when administered prior to initiation of osteogenesis. J. Clin. Invest. 1981, 68:815-818.
58. Bosetti M., Boccafoschi F., Leigheb M., Cannas M.F. Effect of different growth factors on human osteoblasts activities: a possible application in bone regeneration for tissue engineering. Biomol. Eng. 2007, 24:613-618.
59. Caplan A.I. New era of cell-based orthopedic therapies. Tissue Eng. Part B Rev. 2009, 15:195-200.
60. Lee K., Chan C.K., Patil N., Goodman S.B. Cell therapy for bone regeneration - bench to bedside. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 89:252-263.
61. Lang I., Schweizer A., Hiden U., Ghaffari-Tabrizi N., Hagendorfer G., Bilban M., Pabst M.A., Korgun E.T., Dohr G., Desoye G. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 2008, 76:1031-1043.
62. Sun H., Feng K., Hu J., Soker S., Atala A., Ma P.X. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 2010, 31:1133-1139.
63. Wang L., Singh M., Bonewald L.F., Detamore M.S. Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J. Tissue Eng. Regen. Med. 2009, 3:398-404.
64. Harkness L., Mahmood A., Ditzel N., Abdallah B.M., Nygaard J.V., Kassem M. Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential. Bone 2011, 48:231-241.
65. Kärner E., Unger C., Sloan A.J., Ährlund-Richter L., Sugars R.V., Wendel M. Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cell Dev. 2007, 16:39-52.
66. Kawaguchi J., Mee P.J., Smith A.G. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Bone 2005, 36:758-769.
67. D'Ippolito G., Diabira S., Howard G.A., Roos B.A., Schiller P.C. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 2006, 39:513-522.
68. Li F., Bronson S., Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J. Cell. Biochem. 2010, 109:643-652.
69. Shimizu T., Tanaka T., Iso T., Doi H., Sato H., Kawai-Kowase K., Arai M., Kurabayashi M. Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells: role of Msx2 gene induction via Notch-RBP-Jk signaling. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1104-1111.
70. Jeon O., Song S.J., Yang H.S., Bhang S.-H., Kang S.-W., Sung M.A., Lee J.H., Kim B.-S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem. Biophys. Res. Comm. 2008, 369:774-780.
71. Tabata Y. Regenerative inductive therapy based on DDS technology of protein and gene. J. Drug Target. 2006, 14:483-495.
72. Kempen D.H.R., Lu L., Hefferan T.E., Creemers L.B., Maran A., Classic K.L., Dhert W.J.A., Yaszemski M.J. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008, 29:3245-3252.
73. Kanzaki S., Takahashi T., Kanno T., Ariyoshi W., Shinmyouzu K., Tujisawa T., Nishihara T. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. J. Cell. Physiol. 2008, 216:844-850.
74. Kempen D.H., Yaszemski M.J., Heijink A., Hefferan T.E., Creemers L.B., Britson J., Maran A., Classic K.L., Dhert W.J., Lu L. Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. J. Control. Release 2009, 134:169-176.
75. Schliephake H. Application of bone growth factors - the potential of different carrier systems. Oral Maxillof. Surg. 2010, 14:17-22.
76. Ziegler J., Anger D., Krummenauer F., Breitig D., Fickert S., Guenther K.-P. Biological activity of recombinant human growth factors released from biocompatible bone implants. J. Biomed. Mater. Res. A 2008, 86:89-97.
77. Kang S.M., Kong B., Oh E., Choi J.S., Choi I.S. Osteoconductive conjugation of bone morphogenetic protein-2 onto titanium/titanium oxide surfaces coated with non-biofouling poly(poly(ethylene glycol) methacrylate). Coll. Surf. B Biointerfaces 2010, 75:385-389.
78. Shi Z., Neoh K.G., Kang E.-T., Poh C., Wang W. Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Eng. Part A 2009, 15:417-426.
79. Stadlinger B., Pilling E., Huhle M., Mai R., Bierbaum S., Scharnweber D., Kuhlisch E., Loukota R., Eckelt U. Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study. Int. J. Oral Maxillof. Surg. 2008, 37:54-59.
80. Liu H., Webster T.J. Ceramic/polymer nanocomposites with tunable drug delivery capability at specific disease sites. J. Biomed. Mater. Res. A 2010, 93:1180-1192.
81. Ehlert N., Hoffmann A., Luessenhop T., Gross G., Mueller P.P., Stieve M., Lenarz T., Behrens P. Amino-modified silica surfaces efficiently immobilize bone morphogenetic protein 2 (BMP2) for medical purposes. Acta Biomater. 2011, 7:1772-1779.
82. Schuessele A., Mayr H., Tessmar J., Goepferich A. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J. Biomed. Mater. Res. A 2009, 90:959-971.
83. Wernike E., Hofstetter W., Liu Y., Wu G., Sebald H.-J., Wismeijer D., Hunziker E.B., Siebenrock K.-A., Klenke F.M. Long-term cell-mediated protein release from calcium phosphate ceramics. J. Biomed. Mater. Res. A 2010, 92:463-474.
84. Tsurushima H., Marushima A., Suzuki K., Oyane A., Sogo Y., Nakamura K., Matsumura A., Ito A. Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2. Acta Biomater. 2010, 6:2751-2759.
85. Habraken W., Wolke J., Jansen J. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug Deliv. Rev 2007, 59:234-248.
86. Komaki H., Tanaka T., Chazono M., Kikuchi T. Repair of segmental bone defects in rabbit tibiae using a complex of beta-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 2006, 27:5118-5126.
87. Chu T.-M.G., Warden S.J., Turner C.H., Stewart R.L. Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2. Biomaterials 2007, 28:459-467.
88. Fei Z., Hu Y., Wu D., Wu H., Lu R., Bai J., Song H. Preparation and property of a novel bone graft composite consisting of rhBMP-2 loaded PLGA microspheres and calcium phosphate cement. J. Mater. Sci. Mater. Med. 2008, 19:1109-1116.
89. Xu H.H.K., Weir M.D., Simon C.G. Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration. Dent. Mater. 2008, 24:1212-1222.
90. Gerhardt L.-C., Widdows K.L., Erol M.M., Burch C.W., Sanz-Herrera J.A., Ochoa I., Stämpfli R., Roqan I.S., Gabe S., Ansari T., Boccaccini A.R. The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds. Biomaterials 2011, 32:4096-4108.
91. Ginebra M.P., Traykova T., Planell J.A. Calcium phosphate cements as bone drug delivery systems: a review. J. Control. Release 2006, 113:102-110.
92. Kroese-Deutman H.C., Ruhé P.Q., Spauwen P.H.M., Jansen J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials 2005, 26:1131-1138.
93. Link D.P., van den Dolder J., van den Beucken J.J., Wolke J.G., Mikos A.G., Jansen J.A. Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-beta 1 loaded gelatin microparticles. Biomaterials 2008, 29:675-682.
94. Seeherman H.J., Azari K., Bidic S., Rogers L., Li X.J., Hollinger J.O., Wozney J.M. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J. Bone Joint Surg. 2006, 88:1553-1565.
95. Leeuwenburgh S.C.G., Jo J., Wang H., Yamamoto M., Jansen J.A., Tabata Y. Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration. Biomacromolecules 2010, 11:2653-2659.
96. Wu C., Zreiqat H. Porous bioactive diopside (CaMgSi(2)O(6)) ceramic microspheres for drug delivery. Acta Biomater. 2010, 6:820-829.
97. Ishibe T., Goto T., Kodama T., Miyazaki T., Kobayashi S., Takahashi T. Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009, 108:867-875.
98. Kashiwagi K., Tsuji T., Shiba K. Directional BMP-2 for functionalization of titanium surfaces. Biomaterials 2009, 30:1166-1175.
99. Wolf-brandstetter C., Lode A., Hanke T., Scharnweber D., Worch H. Influence of modified extracellular matrices on Ti6AL4V implants on binding and release of VEGF. J. Biomed. Mater. Res. A 2006, 79:882-894.
100. Beutner R., Michael J., Förster A., Schwenzer B., Scharnweber D. Immobilization of oligonucleotides on titanium based materials by partial incorporation in anodic oxide layers. Biomaterials 2009, 30:2774-2781.
101. Le Guéhennec L., Soueidan A., Layrolle P., Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent. Mater. 2007, 23:844-854.
102. Puleo D., Kissling R., Sheu M. A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials 2002, 23:2079-2087.
103. Balasundaram G., Shimpi T.M., Sanow W.R., Storey D.M., Kitchell B.S., Webster T.J. Molecular plasma deposited peptides on anodized nanotubular titanium: an osteoblast density study. J. Biomed. Mater. Res. A 2011, 98:192-200.
104. Choi J., Konno T., Takai M., Ishihara K. Controlled drug release from multilayered phospholipid polymer hydrogel on titanium alloy surface. Biomaterials 2009, 30:5201-5208.
105. Morra M., Cassinelli C., Cascardo G., Cahalan P., Cahalan L., Fini M., Giardino R. Surface engineering of titanium by collagen immobilization. Surface characterization and in vitro and in vivo studies, Biomaterials 2003, 24:4639-4654.
106. Paital S.R., Dahotre N.B. Calcium phosphate coatings for bio-implant applications: materials, performance factors, and methodologies. Mater. Sci. Eng. R 2009, 66:1-70.
107. Ichinohe N., Kuboki Y., Tabata Y. Bone regeneration using titanium nonwoven fabrics combined with fgf-2 release from gelatin hydrogel microspheres in rabbit skull defects. Tissue Eng. Part A 2008, 14:1663-1671.
108. Liu Y., de Groot K., Hunziker E.B. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005, 36:745-757.
109. Malafaya P.B., Silva G.A., Reis R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Advanced drug delivery reviews 2007, 59:207-233.
110. Geiger M., Li R.H., Friess W. Collagen sponges for bone regeneration with rhBMP-2. Bone 2003, 55:1613-1629.
111. Luca L., Rougemont A.-L., Walpoth B.H., Gurny R., Jordan O. The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation. J. Control. Release 2010, 147:38-44.
112. Morin R., Kaplan D., Perez-Ramirez B. Bone morphogenetic protein-2 binds as multilayers to a collagen delivery matrix: an equilibrium thermodynamic analysis. Biomacromolecules 2006, 7:131-138.
113. Uludag H., D'Augusta D., Palmer R., Timony G., Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in rat ectopic model. J. Biomed. Mater. Res. 1999, 46:193-202.
114. Edlund U., Dånmark S., Albertsson A.-C. A strategy for the covalent functionalization of resorbable polymers with heparin and osteoinductive growth factor. Biomacromolecules 2008, 9:901-905.
115. Ho Y.-C., Mi F.-L., Sung H.-W., Kuo P.-L. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor. Int. J. Pharm. 2009, 376:69-75.
116. Yang H.S., La W.-G., Bhang S.H., Jeon J.-Y., Lee J.H., Kim B.-S. Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. Tissue Eng. Part A 2010, 16:1225-1233.
117. Yang W.D., Gomes R.R., Alicknavitch M., Farach-Carson M.C., Carson D.D. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds. Tissue Eng. 2005, 11:76-89.
118. Chen B., Lin H., Wang J., Zhao Y., Wang B., Zhao W., Sun W., Dai J. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 2007, 28:1027-1035.
119. Zhao Y., Zhang J., Wang X., Chen B., Xiao Z., Shi C., Wei Z., Hou X., Wang Q., Dai J. The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies. J. Control. Release 2010, 141:30-37.
120. Kim H.D., Valentini R.F. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J. Biomed. Mater. Res. 2002, 59:573-584.
121. Wongpanit P., Ueda H., Tabata Y., Rujiravanit R. In vitro and in vivo release of basic fibroblast growth factor using a silk fibroin scaffold as delivery carrier. J. Biomater. Sci. Polym. Ed. 2010, 21:1403-1419.
122. Jeon O., Powell C., Solorio L.D., Krebs M.D., Alsberg E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. J. Control. Release 2011, 154:258-266.
123. He Q., Zhao Y., Chen B., Xiao Z., Zhang J., Chen L., Chen W., Deng F., Dai J. Improved cellularization and angiogenesis using collagen scaffolds chemically conjugated with vascular endothelial growth factor. Acta Biomater. 2011, 7:1084-1093.
124. Niu X., Feng Q., Wang M., Guo X., Zheng Q. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J. Control. Release 2009, 134:111-117.
125. Wu B., Zheng Q., Guo X., Wu Y., Wang Y., Cui F. Preparation and ectopic osteogenesis in vivo of scaffold based on mineralized recombinant human-like collagen loaded with synthetic BMP-2-derived peptide. Biomed. Mater. 2008, 3:044111.
126. Yang H., La W., Bhang S., Lee T., Lee M., Kim B.-S. Apatite-coated collagen scaffold for bone morphogenetic protein-2 delivery. Tissue Eng. Part A 2011, 17:1-12.
127. Zhao J., Shinkai M., Takezawa T., Ohba S., Chung U.-I., Nagamune T. Bone regeneration using collagen type I vitrigel with bone morphogenetic protein-2. J. Biosci. Bioeng. 2009, 107:318-323.
128. Puppi D., Chiellini F., Piras A.M., Chiellini E. Polymeric materials for bone and cartilage repair. Prog. Polym. Sci 2010, 35:403-440.
129. Stevens B., Yang Y., Mohandas A., Stucker B., Nguyen K.T. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 85:573-582.
130. Lin Z.-Y., Duan Z.-X., Guo X.-D., Li J.-F., Lu H.-W., Zheng Q.-X., Quan D.-P., Yang S.-H. Bone induction by biomimetic PLGA-(PEG-ASP)n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo. J. Control. Release 2010, 144:190-195.
131. Schliephake H., Weich H.A., Dullin C., Gruber R., Frahse S. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid - an experimental study in rats. Biomaterials 2008, 29:103-110.
132. Wei G., Jin Q., Giannobile W.V., Ma P.X. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007, 28:2087-2096.
133. Oest M.E., Dupont K.M., Kong H.-J., Mooney D.J., Guldberg R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J. Orthop. Res. 2007, 25:941-950.
134. Kim J., Yaszemski M.J., Lu L. Three-dimensional porous biodegradable polymeric scaffolds fabricated with biodegradable hydrogel porogens. Tissue Eng Part C Methods 2009, 15:583-594.
135. Whang K., Goldstick T.K., Healy K.E. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials 2000, 21:2545-2551.
136. Yang X.B., Whitaker M.J., Sebald W., Clarke N., Howdle S.M., Shakesheff K.M., Oreffo R.O.C. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng. 2004, 10:1037-1045.
137. Kanczler J.M., Ginty P.J., Barry J.J.A., Clarke N.M.P., Howdle S.M., Shakesheff K.M., Oreffo R.O.C. The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials 2008, 29:1892-1900.
138. Sahoo S., Ang L.T., Goh J.C.-H., Toh S.-L. Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications. J. Biomed. Mater. Res. A 2010, 93:1539-1550.
139. Fu Y.-C., Nie H., Ho M.-L., Wang C.-K., Wang C.-H. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol. Bioeng. 2008, 99:996-1006.
140. Srouji S., Ben-David D., Lotan R., Livne E., Avrahami R., Zussman E. Slow release human recombinant bone morphogenetic protein-2 embedded within electrospun scaffolds for regeneration of bone defect: in vitro and in vivo evaluation. Bone 2011, 17:269-277.
141. Rai B., Teoh S.H., Hutmacher D.W., Cao T., Ho K.H. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 2005, 26:3739-3748.
142. de Mulder E.L.W., Buma P., Hannink G. Anisotropic porous biodegradable scaffolds for musculoskeletal tissue engineering. Materials 2009, 2:1674-1696.
143. Sawyer A.A., Song S.J., Susanto E., Chuan P., Lam C.X.F., Woodruff M.A., Hutmacher D.W., Cool S.M. The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2. Biomaterials 2009, 30:2479-2488.
144. Zara J.N., Siu R.K., Zhang X., Shen J., Ngo R., Lee M., Li W., Chiang M., Chung J., Kwak J., Wu B.M., Ting K., Soo C. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Anim. Res. 2011, 17:1389-1399.
145. Ruhé P.Q., Boerman O.C., Russel F.G.M., Spauwen P.H.M., Mikos A.G., Jansen J.A. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J. Control. Release 2005, 106:162-171.
146. Bodde E.W.H., Boerman O.C., Russel F.G.M., Mikos A.G., Spauwen P.H.M., Jansen J.A. The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J. Biomed. Mater. Res. A 2008, 87:780-791.
147. Félix Lanao R.P., Leeuwenburgh S.C.G., Wolke J.G.C., Jansen J.A. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. Acta Biomater. 2011, 7:3459-3468.
148. Phillips F.M., Turner S., Seim H.B., MacLeay J., Toth C.A., Pierce A.R., Wheeler D.L. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J. 2006, 6:500-506.
149. Lochmann A., Nitzsche H., von Einem S., Schwarz E., Mäder K. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres. J. Control. Release 2010, 147:92-100.
150. Shen H., Hu X., Yang F., Bei J., Wang S. An injectable scaffold: rhBMP-2-loaded poly(lactide-co-glycolide)/hydroxyapatite composite microspheres. Acta Biomater. 2010, 6:455-465.
151. Patel Z.S., Yamamoto M., Ueda H., Tabata Y., Mikos A.G. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater. 2008, 4:1126-1138.
152. P.C. Bessa, E.R. Balmayor, H.S. Azevedo, S. Nürnberger, M. Casal, M. van Griensven, R.L. Reis, H. Redl, Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release., Tissue Eng. Part C Meth., 16 (2010) 937-945.
153. Chen F., Wu Z., Sun H., Wu H., Xin S., Wang Q.-T., Dong G., Ma Z., Huang S., Zhang Y., Jin Y. Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept. Int. J. Pharm. 2006, 307:23-32.
154. Lee J.-Y., Kim K.-H., Shin S.-Y., Rhyu I.-C., Lee Y.-M., Park Y.-J., Chung C.-P., Lee S.-J. Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules. J. Biomed. Mater. Res. A 2006, 76:530-539.
155. Lee M., Li W., Siu R.K., Whang J., Zhang X., Soo C., Ting K., Wu B.M. Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. Biomaterials 2009, 30:6094-6101.
156. Chan O.C.M., So K.-F., Chan B.P. Fabrication of nano-fibrous collagen microspheres for protein delivery and effects of photochemical crosslinking on release kinetics. J. Control. Release 2008, 129:135-143.
157. De la Riva B., Nowak C., Sánchez E., Hernández A., Schulz-Siegmund M., Pec M.K., Delgado A., Evora C. VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds. Eur. J. Pharm. Biopharm. 2009, 73:50-58.
158. Jaklenec A., Hinckfuss A., Bilgen B., Ciombor D.M., Aaron R., Mathiowitz E. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials 2008, 29:1518-1525.
159. Kim K., Fisher J.P. Nanoparticle technology in bone tissue engineering. J. Drug Target. 2007, 15:241-252.
160. Zhang S., Uludaǧ H. Nanoparticulate systems for growth factor delivery. Pharm. Res. 2009, 26:1561-1580.
161. Mercado A.E., Jabbari E. Effect of encapsulation or grafting on release kinetics of recombinant human bone morphogenetic protein-2 from self-assembled poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles. Microsc. Res. Techniq. 2010, 73:824-833.
162. Chen L., Liu L., Li C., Tan Y., Zhang G. A new growth factor controlled drug release system to promote healing of bone fractures: Nanospheres of recombinant human bone morphogenetic-2 and polylactic acid. J. Nanosci. Nanotechnol. 2011, 11:3107-3114.
163. Yilgor P., Hasirci N., Hasirci V. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J. Biomed. Mater. Res. A 2009, 93:528-536.
164. Nandagiri V.K., Gentile P., Chiono V., Tonda-Turo C., Matsiko A., Ramtoola Z., Montevecchi F.M., Ciardelli G. Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. J. Mech. Behav. Biomed. 2011, 4:1318-1327.
165. Chung Y.-I., Ahn K.-M., Jeon S.-H., Lee S.-Y. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J. Control. Release 2007, 121:91-99.
166. S. Mourtas, S. Fotopoulou, S. Duraj, V. Sfika, C. Tsakiroglou, S.G. Antimisiaris, Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics., Coll. Surf. B Biointerfaces, 55 (2007) 212-221.
167. Dai C., Wang B., Zhao H., Li B. Factors affecting protein release from microcapsule prepared by liposome in alginate. Coll. Surf. B Biointerfaces 2005, 42:253-258.
168. Wang H., Zhao P., Su W., Wang S., Liao Z., Niu R., Chang J. PLGA/polymeric liposome for targeted drug and gene co-delivery. Biomaterials 2010, 31:8741-8748.
169. Haidar Z.S., Tabrizian M., Hamdy R.C. A hybrid rhOP-1 delivery system enhances new bone regeneration and consolidation in a rabbit model of distraction osteogenesis. Growth Factors 2010, 28:44-55.
170. Johnson M.R., Lee H.-J., Bellamkonda R.V., Guldberg R.E. Sustained release of BMP-2 in a lipid-based microtube vehicle. Acta Biomater. 2009, 5:23-28.
171. Lin C.-C., Metters A.T. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv. Drug Deliv. Rev 2006, 58:1379-1408.
172. Young S., Wong M., Tabata Y., Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release 2005, 109:256-274.
173. Kolambkar Y.M., Dupont K.M., Boerckel J.D., Huebsch N., Mooney D.J., Hutmacher D.W., Guldberg R.E. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 2011, 32:65-74.
174. Kim J., Kim I.S., Cho T.H., Lee K.B., Hwang S.J., Tae G., Noh I., Lee S.H., Park Y., Sun K. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 2007, 28:1830-1837.
175. Lin C.-C., Anseth K.S. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm. Res. 2009, 26:631-643.
176. Patterson J., Siew R., Herring S.W., Lin A.S.P., Guldberg R., Stayton P.S. Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials 2010, 31:6772-6781.
177. Yamamoto M., Takahashi Y., Tabata Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng. 2006, 12:1305-1311.
178. Kimura Y., Miyazaki N., Hayashi N., Otsuru S., Tamai K., Kaneda Y., Tabata Y. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng. Part A 2010, 16:1263-1270.
179. Kim J., Hefferan T.E., Yaszemski M.J., Lu L. Potential of hydrogels based on poly(ethylene glycol) and sebacic acid as orthopedic tissue engineering scaffolds. Tissue Eng. Part A 2009, 15:2299-2307.
180. Zhang Y., Wu X., Han Y., Mo F., Duan Y., Li S. Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels. Int. J. Pharm. 2010, 386:15-22.
181. Bencherif S.A., Sheehan J.A., Hollinger J.O., Walker L.M., Matyjaszewski K., Washburn N.R. Influence of cross-linker chemistry on release kinetics of PEG-co-PGA hydrogels. J. Biomed. Mater. Res. A 2009, 90:142-153.
182. Cho E., Kutty J.K., Datar K., Lee J.S., Vyavahare N.R., Webb K. A novel synthetic route for the preparation of hydrolytically degradable synthetic hydrogels. J. Biomed. Mater. Res. A 2009, 90:1073-1082.
183. Burdick J.A., Mason M.N., Hinman A.D., Thorne K., Anseth K.S. Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. J. Control. Release 2002, 83:53-63.
184. Shin H., Quinten Ruhé P., Mikos A.G., Jansen J.A. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials 2003, 24:3201-3211.
185. Kaito T., Myoui A., Takaoka K., Saito N., Nishikawa M., Tamai N., Ohgushi H., Yoshikawa H. Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials 2005, 26:73-79.
186. Terella A., Mariner P., Brown N., Anseth K., Streubel S.-O. Repair of a calvarial defect with biofactor and stem cell-embedded polyethylene glycol scaffold. Arch. Fac. Plast. Surg. 2010, 12:166-171.
187. Jo Y.S., Rizzi S.C., Ehrbar M., Weber F.E., Hubbell J.A., Lutolf M.P. Biomimetic PEG hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides. J. Biomed. Mater. Res. A 2009, 93:870-877.
188. Shin H., Zygourakis K., Farach-Carson M.C., Yaszemski M.J., Mikos A.G. Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials 2004, 25:895-906.
189. Shin H., Zygourakis K., Farach-Carson M.C., Yaszemski M.J., Mikos A.G. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J. Biomed. Mater. Res. A 2004, 69:535-543.
190. Gkioni K., Leeuwenburgh S.C.G., Douglas T.E.L., Mikos A.G., Jansen J.A. Mineralization of hydrogels for bone regeneration. Tissue Eng. Part A 2010, 16:577-585.
191. Mano J.F. Stimuli-responsive polymeric systems for biomedical applications. Adv. Eng. Mater. 2008, 10:515-527.
192. Garbern J.C., Hoffman A.S., Stayton P.S. Injectable pH- and temperature-responsive poly (N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules 2010, 11:1833-1839.
193. Shi J., Liu L., Liu X., Sun X., Cao S. Inorganic-organic hybrid alginate beads with LCST near human body temperature for sustained dual-sensitive drug delivery. Polym. Adv. Technol. 2008, 19:1467-1473.
194. Na K., Kim S.W., Sun B.K., Woo D.G., Yang H.N., Chung H.M., Park K.H. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials 2007, 28:2631-2637.
195. Chun C., Lim H.J., Hong K.-Y., Park K.-H., Song S.-C. The use of injectable, thermosensitive poly(organophosphazene)-RGD conjugates for the enhancement of mesenchymal stem cell osteogenic differentiation. Biomaterials 2009, 30:6295-6308.
196. He C., Kim S.W., Lee D.S. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J. Control. Release 2008, 127:189-207.
197. Kim M.S., Kim S.K., Kim S.H., Hyun H., Khang G., Lee H.B. In vivo osteogenic differentiation of rat bone marrow stromal cells in thermosensitive MPEG-PCL diblock copolymer gels. Tissue Eng. 2006, 12:2863-2873.
198. Patois E., Osorio-da Cruz S., Tille J.-C., Walpoth B., Gurny R., Jordan O. Novel thermosensitive chitosan hydrogels: in vivo evaluation. J. Biomed. Mater. Res. A 2009, 91:324-330.
199. Bessa P.C., Machado R., Nürnberger S., Dopler D., Banerjee A., Cunha A.M., Rodríguez-Cabello J.C., Redl H., van Griensven M., Reis R.L., Casal M. Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. J. Control. Release 2010, 142:312-318.
200. Kim H.K., Shim W.S., Kim S.E., Lee K.-H., Kang E., Kim J.-H., Kim K., Kwon I.C., Lee D.S. Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering. Tissue Eng. Part A 2009, 15:923-933.
201. Lutolf M.P., Schmoekel H.G., Metters A.T., Webers F.E., Fieldst G.B., Hubbell J.A. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration : engineering cell-invasion characteristics. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5413-5418.
202. Kim J., Kim I.S., Cho T.H., Kim H.C., Yoon S.J., Choi J., Park Y., Sun K., Hwang S.J. In vivo evaluation of MMP sensitive high-molecular weight HA-based hydrogels for bone tissue engineering. J. Biomed. Mater. Res. A 2010, 95:673-681.
203. Chung E.H., Gilbert M., Virdi A.S., Sena K., Sumner D.R., Healy K.E. Biomimetic artificial ECMs stimulate bone regeneration. J. Biomed. Mater. Res. A 2006, 79:815-826.
204. Arrighi I., Mark S., Alvisi M., von Rechenberg B., Hubbell J.A., Schense J.C. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials 2009, 30:1763-1771.
205. Ulijn R.V., Bibi N., Jayawarna V., Thornton P.D., Todd S.J., Mart R.J., Smith A.M., Gough J.E. Bioresponsive hydrogels. Mater. Today 2007, 10:40-48.
206. Bock N., Riminucci A., Dionigi C., Russo A., Tampieri A., Landi E., Goranov V.A., Marcacci M., Dediu V. A novel route in bone tissue engineering: magnetic biomimetic scaffolds. Acta Biomater. 2010, 6:786-796.
207. Tampieri A., Landi E., Valentini F., Sandri M., D'Alessandro T., Dediu V., Marcacci M. A conceptually new type of bio-hybrid scaffold for bone regeneration. Nanotechnology 2011, 22:1-8.
208. Tsiridis E., Upadhyay N., Giannoudis P. Molecular aspects of fracture healing: which are the important molecules?. Injury 2007, 38(Suppl 1):S11-S25.
209. Chen F.-M., Zhang M., Wu Z.-F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31:6279-6308.
210. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 2001, 19:1029-1034.
211. Simmons C.A., Alsberg E., Hsiong S., Kim W.J., Mooney D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004, 35:562-569.
212. Chen F.-M., Chen R., Wang X.-J., Sun H.-H., Wu Z.-F. In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 2009, 30:5215-5224.
213. Kanczler J.M., Ginty P.J., White L., Clarke N.M.P., Howdle S.M., Shakesheff K.M., Oreffo R.O.C. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010, 31:1242-1250.
214. Park H., Temenoff J.S., Tabata Y., Caplan A.I., Raphael R.M., Jansen J.A., Mikos A.G. Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J. Biomed. Mater. Res. A 2009, 88:889-897.
215. Facca S., Cortez C., Mendoza-Palomares C., Messadeq N., Dierich A., Johnston A.P.R., Mainard D., Voegel J.-C., Caruso F., Benkirane-Jessel N. Active multilayered capsules for in vivo bone formation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3406-3411.
216. Shah N.J., Macdonald M.L., Beben Y.M., Padera R.F., Samuel R.E., Hammond P.T. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 2011, 32:6183-6193.
217. Choi D.H., Park C.H., Kim I.H., Chun H.J., Park K., Han D.K. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system. J. Control. Release 2010, 147:193-201.
218. Young S., Patel Z.S., Kretlow J.D., Murphy M.B., Mountziaris P.M., Baggett L.S., Ueda H., Tabata Y., Jansen J.A., Wong M., Mikos A.G. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng. Part A 2009, 15:2347-2362.
219. Basmanav F.B., Kose G.T., Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008, 29:4195-4204.
220. Wang X., Wenk E., Zhang X., Meinel L., Vunjak-Novakovic G., Kaplan D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J. Control. Release 2009, 134:81-90.
221. Yang P.J., Temenoff J.S. Engineering orthopedic tissue interfaces. Tissue Eng Part B Rev 2009, 15:127-141.
222. Holland T.A., Bodde E.W.H., Cuijpers V.M.J.I., Baggett L.S., Tabata Y., Mikos A.G., Jansen J.A. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthr. Cart. 2007, 15:187-197.
223. Guo X., Liao J., Park H., Saraf A., Raphael R.M., Tabata Y., Kasper F.K., Mikos A.G. Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater. 2010, 6:2920-2931.
224. Guo X., Park H., Liu G., Liu W., Cao Y., Tabata Y., Kasper F.K., Mikos A.G. In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials 2009, 30:2741-2752.
225. Anitua E., Sanchez M., Orive G., Andia I. Delivering growth factors for therapeutics. Tr. Pharmacol. Sci. 2007, 29:37-41.
226. Lu H.H., Vo J.M., Chin H.S., Lin J., Cozin M., Tsay R., Eisig S., Landesberg R. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J. Biomed. Mater. Res. A 2008, 86:1128-1136.
227. Hokugo A., Sawada Y., Hokugo R., Iwamura H., Kobuchi M., Kambara T., Morita S., Tabata Y. Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007, 104:44-48.
228. Gallego L., Junquera L., García E., García V., Alvarez-Viejo M., Costilla S., Fresno M.F., Meana A. Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold. Tissue Eng. Part A 2010, 16:1179-1187.
229. Kasten P., Vogel J., Geiger F., Niemeyer P., Luginbühl R., Szalay K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 2008, 29:3983-3992.
230. Bi L., Cheng W., Fan H., Pei G. Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma. Biomaterials 2010, 31:3201-3211.
231. Kretlow J.D., Spicer P.P., Jansen J.A., Vacanti C.A., Kasper F.K., Mikos A.G. Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects. Tissue Eng. Part A 2010, 16:3555-3568.
232. Yang C., Frei H., Rossi F.M., Burt H.M. The differential in vitro and in vivo responses of bone marrow stromal cells on novel porous gelatin-alginate scaffolds. J. Tissue Eng. Regen. Med. 2009, 3:601-614.
233. Chan B.P., Hui T.Y., Wong M.Y., Yip K.H.K., Chan G.C.F. Mesenchymal stem cell-encapsulated collagen microspheres for bone tissue engineering. Tissue Eng. Part C Meth. 2010, 16:225-235.
234. Park S.-H., Tofighi A., Wang X., Strunk M., Ricketts T., Chang J., Kaplan D.L. Calcium phosphate combination biomaterials as human mesenchymal stem cell delivery vehicles for bone repair. J. Biomed. Mater. Res. B Appl. Biomater. 2011, 97:235-244.
235. Moreau J.L., Xu H.H.K. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold. Biomaterials 2009, 30:2675-2682.
236. Lee G.-S., Park J.-H., Shin U.S., Kim H.-W. Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug delivery and bone tissue engineering. Acta Biomater. 2011, 7:3178-3186.
237. Klouda L., Perkins K.R., Watson B.M., Hacker M.C., Bryant S.J., Raphael R.M., Kasper F.K., Mikos A.G. Thermoresponsive, in situ cross-linkable hydrogels based on N-isopropylacrylamide: fabrication, characterization and mesenchymal stem cell encapsulation. Acta Biomater. 2011, 7:1460-1467.
238. Zimmermann G., Gierloff M., Hedderich J., Acil Y., Wiltfang J., Terheyden H. Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo. Tissue Eng. Part A 2011, 17:1147-1156.
239. Grellier M., Bordenave L., Amedee J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol. 2009, 27:562-571.
240. Sun H., Qu Z., Guo Y., Zang G., Yang B. In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds. Biomed. Eng. Online 2007, 6:41.
241. Xue Y., Xing Z., Hellem S., Arvidson K., Mustafa K. Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed. Eng. Online 2009, 8:34.
242. Tao J., Sun Y., Wang Q.G., Liu C.W. Induced endothelial cells enhance osteogenesis and vascularization of mesenchymal stem cells. Cells Tissues Organs 2009, 190:185-193.
243. Zhou J., Lin H., Fang T., Li X., Dai W., Uemura T., Dong J. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. Biomaterials 2010, 31:1171-1179.
244. Koob S., Torio-Padron N., Stark G.B., Hannig C., Stankovic Z., Finkenzeller G. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng. Part A 2011, 17:311-321.
245. Choong C.S., Hutmacher D.W., Triffitt J.T. Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering. Tissue Eng. 2006, 12:2521-2531.
246. Grellier M., Granja P.L., Fricain J.C., Bidarra S.J., Renard M., Bareille R., Bourget C., Amedee J., Barbosa M.A. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009, 30:3271-3278.
247. Santos M.I., Unger R.E., Sousa R.A., Reis R.L., Kirkpatrick C.J. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. Biomaterials 2009, 30:4407-4415.
248. Yu H., Vandevord P.J., Gong W., Wu B., Song Z., Matthew H.W., Wooley P.H., Yang S.Y. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J. Orthop. Res. 2008, 26:1147-1152.
249. Fuchs S., Hofmann A., Kirkpatrick C.J. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng. 2007, 13:2577-2588.
250. Hofmann A., Ritz U., Verrier S., Eglin D., Alini M., Fuchs S., Kirkpatrick C.J., Rommens P.M. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 2008, 29:4217-4226.
251. Yeatts A.B., Fisher J.P. Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone 2011, 48:171-181.
252. Rauh J., Milan F., Gu K.-P., Stiehler M. Bioreactor systems for bone tissue engineering. Tissue Eng. Part B Rev. 2011, 17:263-280.
253. Bancroft G.N., Sikavitsas V.I., Mikos A.G. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng. 2003, 9:549-554.
254. Holtorf H.L., Jansen J.A., Mikos A.G. Flow perfusion culture induces the osteoblastic differentiation of marrow stromal cell-scaffold constructs in the absence of dexamethasone. J. Biomed. Mater. Res. A 2005, 72:326-334.
255. Datta N., Pham Q.P., Sharma U., Sikavitsas V.I., Jansen J.A., Mikos A.G. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2488-2493.
256. Pham Q.P., Kasper F.K., Mistry A.S., Sharma U., Yasko A.W., Jansen J.A., Mikos A.G. Analysis of the osteoinductive capacity and angiogenicity of an in vitro generated extracellular matrix. J. Biomed. Mater. Res. A 2009, 88:295-303.
257. Liao J., Guo X., Nelson D., Kasper F.K., Mikos A.G. Modulation of osteogenic properties of biodegradable polymer/extracellular matrix scaffolds generated with a flow perfusion bioreactor. Acta Biomater. 2010, 6:2386-2393.
258. Kang Y., Kim S., Khademhosseini A., Yang Y. Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. Biomaterials 2011, 32:6119-6130.
259. Thibault R.A., Scott Baggett L., Mikos A.G., Kasper F.K. Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. Tissue Eng. Part A 2010, 16:431-440.
260. Deutsch E.R., Guldberg R.E. Stem cell-synthesized extracellular matrix for bone repair. Journal of Materials Chemistry 2010, 20:8942-8951.
261. Tour G., Wendel M., Tcacencu I. Cell-derived matrix enhances osteogenic properties of hydroxyapatite. Tissue Eng. Part A 2011, 17:127-137.
262. Strohbach C.A., Rundle C.H., Wergedal J.E., Chen S.-T., Linkhart T.A., Lau K.-H.W., Strong D.D. LMP-1 retroviral gene therapy influences osteoblast differentiation and fracture repair: a preliminary study. Calcif. Tissue Int. 2008, 83:202-211.
263. Lee J.-S., Lee J.-M., Im G.-I. Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells. Biomaterials 2011, 32:760-768.
264. Jabbarzadeh E., Starnes T., Khan Y.M., Jiang T., Wirtel A.J., Deng M., Lv Q., Nair L.S., Doty S.B., Laurencin C.T. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11099-11104.
265. Kumar S., Wan C., Ramaswamy G., Clemens T.L., Ponnazhagan S. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol. Ther. 2010, 18:1026-1034.
266. Li R., Stewart D.J., von Schroeder H.P., Mackinnon E.S., Schemitsch E.H. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J. Orthop. Res. 2009, 27:8-14.
267. Miyazaki M., Zuk P.A., Zou J., Yoon S.H., Wei F., Morishita Y., Sintuu C., Wang J.C. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Spine 2008, 33:863-869.
268. Meinel L., Hofmann S., Betz O., Fajardo R., Merkle H.P., Langer R., Evans C.H., Vunjak-Novakovic G., Kaplan D.L. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials 2006, 27:4993-5002.
269. Pelled G., Ben-Arav A., Hock C., Reynolds D.G., Yazici C., Zilberman Y., Gazit Z., Awad H., Gazit D., Schwarz E.M. Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. Tissue Eng. Part B Rev. 2010, 16:13-20.
270. Chen Y., Luk K.D., Cheung K.M., Xu R., Lin M.C., Lu W.W., Leong J.C., Kung H.F. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther. 2003, 10:1345-1353.
271. Miyazaki M., Sugiyama O., Zou J., Yoon S.H., Wei F., Morishita Y., Sintuu C., Virk M.S., Lieberman J.R., Wang J.C. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine 2008, 33:1410-1417.
272. Phillips J.E., Gersbach C.A., García A.J. Virus-based gene therapy strategies for bone regeneration. Biomaterials 2007, 28:211-229.
273. Partridge K.A., Oreffo R.O.C. Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. Tissue Eng. 2004, 10:295-307.
274. Kawai M., Maruyama H., Bessho K., Yamamoto H., Miyazaki J.-I., Yamamoto T. Simple strategy for bone regeneration with a BMP-2/7 gene expression cassette vector. Biochem. Bioph. Res. Comm. 2009, 390:1012-1017.
275. Aslan H., Zilberman Y., Arbeli V., Sheyn D., Matan Y., Liebergall M., Li J.I.N.Z., Helm G.A., Gazit D.A.N., Gazit Z. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng. 2006, 12:877-889.
276. Sheyn D., Kimelman-Bleich N., Pelled G., Zilberman Y., Gazit D., Gazit Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther. 2008, 15:257-266.
277. Fang J., Zhu Y.Y., Smiley E., Bonadio J., Rouleau J.P., Goldstein S.A., McCauley L.K., Davidson B.L., Roessler B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:5753-5758.
278. Chen J., Chen H., Li P., Diao H., Zhu S., Dong L., Wang R., Guo T., Zhao J., Zhang J. Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials 2011, 32:4793-4805.
279. Kolk A., Haczek C., Koch C., Vogt S., Kullmer M., Pautke C., Deppe H., Plank C. A strategy to establish a gene-activated matrix on titanium using gene vectors protected in a polylactide coating. Biomaterials 2011, 32:6850-6859.
280. Kim H.S., Yoo H.S. MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: in vitro and in vivo evaluation. J. Control. Release 2010, 145:264-271.
281. Hu W.-W., Wang Z., Hollister S.J., Krebsbach P.H. Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther. 2007, 14:891-901.
282. Jang J.-H., Schaffer D.V., Shea L.D. Engineering biomaterial systems to enhance viral vector gene delivery. Mol. Ther. 2011, 19:1407-1415.
283. Zhang Y., Fan W., Nothdurft L., Wu C., Zhou Y., Crawford R., Xiao Y. In vitro and in vivo evaluation of adenovirus combined silk fibroin scaffolds for bone morphogenetic protein-7 gene delivery. Tissue Eng. Part C Meth. 2011, 17:789-797.
284. Gafni Y., Pelled G., Zilberman Y., Turgeman G., Apparailly F., Yotvat H., Galun E., Gazit Z., Jorgensen C., Gazit D. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol. Ther. 2004, 9:587-595.
285. Gersbach C.A., Le Doux J.M., Guldberg R.E., García A.J. Inducible regulation of Runx2-stimulated osteogenesis. Gene Ther. 2006, 13:873-882.
286. Peng H., Usas A., Gearhart B., Young B., Olshanski A., Huard J. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol. Ther. 2004, 9:885-894.
287. Koh J.-T., Ge C., Zhao M., Wang Z., Krebsbach P.H., Zhao Z., Franceschi R.T. Use of a stringent dimerizer-regulated gene expression system for controlled BMP2 delivery. Mol. Ther. 2006, 14:684-691.
288. Vehof J.W.M., van den Dolder J., de Ruijter J.E., Spauwen P.H.M., Jansen J. Bone formation in CaP-coated and noncoated titanium fiber mesh. J. Biomed. Mater. Res. A 2003, 64:417-426.
289. Tour G., Wendel M., Tcacencu I. Cell-derived matrix enhances osteogenic properties of hydroxyapatite. Tissue Eng. Part A 2011, 17:127-137.
290. Rundle C.H., Strong D.D., Chen S.-T., Linkhart T.A., Sheng M.H., Wergedal J.E., Lau K.W. Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat. J. Gene Med. 2008, 10:229-241.